(Q34417760)

2 August 2017

title

Ketanserin concentration-effect relationships in individual hypertensive patients (English)

1 reference

2 August 2017

Donnelly R

1

1 reference

2 August 2017

Elliott HL

2

1 reference

2 August 2017

Meredith PA

3

1 reference

2 August 2017

Hughes DM

4

1 reference

2 August 2017

Reid JL

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 July 1988

1 reference

British Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

26

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

61-64

1 reference

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386500

Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386500

Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386500

Acute and chronic ketanserin in essential hypertension: antihypertensive mechanisms and pharmacokinetics

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386500

Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386500

Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blocker

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386500

Clinical studies with ketanserin in hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386500

A comparative and long-term evaluation of ketanserin in the treatment of essential hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386500

Acute blood-pressure-lowering effect of ketanserin

6 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3203061

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Blood pressure reduction and pharmacokinetics of ketanserin in hypertensive patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3203061

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetics of ketanserin in patients with essential hypertension

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3203061

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1988.TB03364.X

1 reference

2 August 2017

1 reference

2 August 2017

1 reference